Historically good results with IL-4 inhibitors raise questions with U.S. audience ...

Good morning, and welcome to the Akebia Therapeutics R&D Day. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Akebia website following ...

Role-playing games as we know them wouldn't be the same today if these ambitious creations hadn't dared to go where no one else would.

Like it or not, big companies are getting trounced by smaller teams. Find out why indie gems are stealing the spotlight from ...

BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...

This is a potentially important study comparing infants (8 months) and adults with respect to rhythmic EEG response properties during periodic and aperiodic visual stimulation. The results provide ...

The CDC was expected last month to publish a study showing that Covid vaccines reduced the likelihood of severe illness, but ...

I initiate coverage on Forte Biosciences stock at a 'Hold' rating due to both pipeline risk and upcoming clinical catalysts.

Forbes contributors publish independent expert analyses and insights. I write about how AI will impact people, business and society. This voice experience is generated by AI. Learn more. This voice ...

While precision seems critical for science, researchers from the U.S. Department of Energy's (DOE) Brookhaven National ...

A new wave of device code phishing shows how threat actors are scaling account compromise using AI and end‑to‑end automation.

Security tech is a mess of broken readers and glitchy updates; the fix isn't more "innovation," but making sure your ...